Prognosis
Pfizer Shot Cleared for Kids 5 to 11 in Pandemic Milestone
- FDA’s action marks new phase in fight against Covid-19
- CDC would need to clear vaccine use before shots given to kids
This article is for subscribers only.
Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was cleared by U.S. regulators for children ages 5 to 11, a long-awaited pandemic milestone that opens a new phase of the immunization campaign.
The emergency authorization, announced Friday in a statement by the Food and Drug Administration, brings the U.S. a step closer to shots being administered at schools, pediatricians’ offices and pharmacies around the country. The formulation for young kids is one-third the dose of the adult shot.